Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PROK | Class A Ordinary Shares | Conversion of derivative security | $0 | +137K | $0.00 | 137K | Aug 25, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PROK | Class B Ordinary Shares | Conversion of derivative security | $0 | -137K | -20.26% | $0.00 | 539K | Aug 25, 2023 | Class A Ordinary Shares | 137K | $0.00 | Direct | F1, F2 |
transaction | PROK | Common Units in ProKidney LP | Conversion of derivative security | $0 | -137K | -20.26% | $0.00 | 539K | Aug 25, 2023 | Class A Ordinary Shares | 137K | $0.00 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis. On August 25, 2023, the reporting person provided ProKidney Corp. (the "Issuer") with notice of exchange, which exchange will be settled 60 days following the closing of the exchange period under the terms of the Exchange Agreement. |
F2 | The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire. |
F3 | The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire. |